The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SPH SINCLAIR PHARMA PLC ORD 1P




We are now using data from FTSE Russell Data Solutions. FTSE Russell is a leading global provider of benchmarks, analytics and data solutions with multi-asset capabilities. Global Company Fundamentals provides profiles on global active and inactive companies from over 100 countries including over 25 years of as-reported financials and standardised financials based on globally accepted XBRL taxonomies for active companies. As a result of this change in data provider, you may see some differences to the data. For further information please contact lse-website@lseg.com
Income Statement 30-Jun-12
( £ m )
30-Jun-13
( £ m )
30-Jun-14
( £ m )
30-Jun-15
( £ m )
31-Dec-16
( £ m )
Continuing Operations
Revenue  51.42 55.38 63.56 75.89 45.49
Operating Profit/(Loss)  -8.49 -15.33 -1.78 4.54 -18.24
Net Interest  -1.17 -0.90 -3.92 -14.46 -11.14
Profit Before Tax  -9.77 -16.98 -4.44 -8.15 -34.03
Profit After Tax  -8.64 -15.85 -4.09 -7.21 -33.40
Discontinued Operations
Profit After Tax  n/a -1.52 -1.21 n/a 3.82
PROFIT FOR THE PERIOD  -8.64 -17.36 -5.30 -7.21 -29.58
Attributable to:
Minority Interests  n/a n/a n/a n/a n/a
Equity Holders of Parent Company  -8.64 -17.36 -5.30 -7.21 -29.58
 
Continuing EPS
Earnings per Share - Basic  -2.20p -3.70p -0.90p -1.50p -6.70p
Earnings per Share - Diluted  -2.20p -3.70p -0.90p -1.50p -6.70p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
Continuing and Discontinued EPS
Earnings per Share - Basic  -2.20p -4.10p -1.20p -1.50p -5.90p
Earnings per Share - Diluted  -2.20p -4.10p -1.20p -1.50p -5.90p
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  n/a n/a n/a n/a n/a

Balance Sheet 30-Jun-12
( £ m )
30-Jun-13
( £ m )
30-Jun-14
( £ m )
30-Jun-15
( £ m )
31-Dec-16
( £ m )
Assets
Non-Current Assets
Property, Plant & Equipment  0.84 0.50 1.40 1.71 1.68
Intangible Assets  129.62 121.36 241.54 232.28 148.88
Investment Properties  n/a n/a n/a n/a n/a
Investments  n/a 0.16 0.16 0.17 0.10
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  0.13 0.00 0.00 0.00 0.00
  135.83 126.17 248.05 237.47 150.66
Current Assets
Inventories  5.83 4.85 7.60 7.62 3.84
Trade & Other Receivables  16.78 19.94 27.51 26.02 13.33
Cash at Bank & in Hand  4.04 5.06 17.53 12.66 16.77
Current Asset Investments  n/a n/a n/a n/a n/a
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  26.65 29.84 54.67 47.95 33.94
 
Total Assets  162.48 156.02 302.72 285.42 184.60
 
Liabilities
Current Liabilities
Borrowings  3.12 3.42 1.24 0.02 n/a
Other Current Liabilities  3.84 11.94 27.01 34.15 22.00
  20.46 24.03 42.88 46.75 26.88
 
Net Current Assets  6.19 5.82 11.79 1.20 7.06
 
Non-Current Liabilities
Borrowings  9.98 8.50 53.32 51.78 0.00
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  4.46 2.02 61.57 54.62 33.32
  27.74 21.45 141.93 133.10 57.40
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  48.20 45.48 184.80 179.84 84.28
 
Net Assets  114.28 110.54 117.92 105.57 100.32
 
Capital & Reserves
Share Capital  n/a n/a n/a n/a n/a
Share Premium Account  58.73 67.24 86.14 86.13 86.13
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  -49.14 -65.88 -70.16 -75.94 -103.29
Shareholders Funds  114.28 110.54 117.92 105.57 100.32
 
Minority Interests/Other Equity  n/a n/a n/a n/a n/a
Total Equity *   114.28 110.54 117.92 105.57 100.32

Ratios - based on IFRS 30-Jun-12 30-Jun-13 30-Jun-14 30-Jun-15 31-Dec-16
Continuing Operations
PE Ratio *   n/a n/a n/a n/a n/a
PEG *   n/a n/a n/a n/a n/a
Earnings per Share Growth  n/a n/a n/a n/a n/a
Dividend Cover *   n/a n/a n/a n/a n/a
Revenue Per Share  13.10p 12.98p 14.29p 15.27p 6.06p
Pre-Tax Profit per Share  -2.49p -3.98p -1.00p -1.64p -4.54p
Operating Margin  -16.51% -27.68% -2.81% 5.99% -40.09%
Return on Capital Employed  -6.48% -12.27% -1.21% 2.75% -9.39%
 
Continuing & Discontinued Operations
Dividend Yield *   n/a n/a n/a n/a n/a
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  -3.81p -2.49p -24.85p -25.47p -9.67p
Net Gearing *   7.93% 6.20% 31.40% 37.07% n/a

Data provided by FTSE Russell



Market

Company Information
Updated Monthly
Company address 1st Floor, Whitfield Court, 30-32 Whitfield Street, London, W1T 2RQ, United Kingdom
Company website http://www.sinclairphar...
Market cap(in millions)* £ 93.70
Listing/Admission to trading 16 Apr 2007
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
21-Apr-18
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AMSM
MiFID Status -
Exchange market size 10,000
SEDOL 3385674
ISIN number GB0033856740



SINCLAIR PHA share fundamentals (SPH)